• About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Contact

Industry Updates

  • Back to News & Insights

Medical Technology M&A Pulse – Q1 2020

  • June 9, 2020
  • Industry Updates
  • Healthcare, Medical Technology
Share on facebook
Share on twitter
Share on linkedin
Featured Pulse Med Q1 2020

In the midst of a global pandemic, medical equipment, and consumable manufacturers, diagnostic test providers, and pharmaceutical / biotechnology developers have been thrust into the spotlight as the government and the public alike lean on them. The critical role these companies play in public health has been underscored as they produce products that keep people safe and limit the spread of infection, help treat those who contract COVID-19, and race in the attempt to develop a cure and vaccine.

Despite their critical role in helping the world overcome the challenges related to COVID-19, the stock performance of medical companies has differed little from that of the broader market during 2020. All four PMCF MedTech indices declined during Q1, with the Diversified Diagnostic Index faring the best at -9.4%, and the Orthopedic Medical Device Index sliding the farthest at -25.2%, likely related to the temporary ban on elective procedures.

While PMCF’s Medical Technology indices reacted sharply to COVID-19 events during the first quarter, as discussed above, as of this report’s May 15th data cut off date all indices had rebounded in a significant way, with the Diversified Diagnostic Index leading the way up 2.1% year to date.

PMCF-Pulse-Medical-Technology-2020-Q1

File size: 2.35 MB
Download Preview

Stay Informed

Subscribe to our newsletter for the latest industry updates

Subscribe

Recent Publications

Plastics & Packaging M&A Update – November 2020
Industrial Distributor M&A Pulse – Q3 2020
Food & Beverage M&A Pulse – Q3 2020
Plastics & Packaging M&A Update – October 2020
Medical Technology M&A Pulse – Q3 2020
Contact

Follow Us On

Securities offered through P&M Corporate Finance, LLC. Member of FINRA and SIPC.

blank
Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

M&A Services

  • Buy Side Advisory
  • Capital Raising
  • Sell Side Advisory
  • Transaction Planning & Readiness Review

Industry Expertise

  • Business Services & Technology
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives
  • Events

©2021 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​
Cookie Notice: This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our Privacy Policy for more information on the cookies we use.AgreePrivacy policy